Stay updated on NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (replacing v3.0.1) and the Back to Top link has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:44:21.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T13:11:22.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new resources related to genetic and rare diseases, particularly in the context of head and neck squamous cell carcinoma and radiation therapy. Several previous terms and categories related to cancer treatment have been removed.
    Difference
    4%
    Check dated 2025-08-31T05:37:42.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T21:17:53.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T17:12:58.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The webpage has added detailed information about a clinical trial involving nivolumab for treating recurrent squamous cell head and neck tumors, including study details, eligibility criteria, and treatment protocols. Additionally, the page now includes a disclaimer about the U.S. government's non-review of all studies listed.
    Difference
    100%
    Check dated 2025-08-02T14:37:11.000Z thumbnail image

Stay in the know with updates to NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.